Cargando…
Surgical treatment for gastrointestinal neuroendocrine tumors
Neuroendocrine tumors (NETs) are rare neoplasms, with an estimated annual incidence of 6.9/100 000. They arise from cells of the diffuse endocrine system, which are mainly dispersed throughout the gastrointestinal (GI), pancreatic, and respiratory tracts. The incidence of GI‐NETs has recently begun...
Autores principales: | Eto, Kojiro, Yoshida, Naoya, Iwagami, Shiro, Iwatsuki, Masaaki, Baba, Hideo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726685/ https://www.ncbi.nlm.nih.gov/pubmed/33319155 http://dx.doi.org/10.1002/ags3.12396 |
Ejemplares similares
-
Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors
por: Iwatsuki, Masaaki, et al.
Publicado: (2018) -
Multiple heterochronic gastrointestinal stromal tumors in the stomach detected 6 years after resection: a case report
por: Yasuda, Tadahito, et al.
Publicado: (2020) -
Laparoscopic surgery for colorectal cancer with persistent descending mesocolon
por: Hiyoshi, Yukiharu, et al.
Publicado: (2019) -
Evaluation of clinical outcomes with propensity‐score matching for colorectal cancer presenting as an oncologic emergency
por: Ogawa, Katsuhiro, et al.
Publicado: (2022) -
Clinical impact of perirenal thickness on short‐ and long‐term outcomes of gastric cancer after curative surgery
por: Eto, Kojiro, et al.
Publicado: (2022)